(Q28732124)

14 December 2023

2

Benjamin Haibe-Kains

Benjamin

Haibe-Kains

1 reference

14 December 2023

10

Eliza Wickham-Garcia

Eliza

Wickham-Garcia

1 reference

14 December 2023

Aedin Culhane

12

Aedin

Culhane

1 reference

14 December 2023

Ronny Drapkin

13

Ronny

Drapkin

1 reference

14 December 2023

1

Stefan Bentink

Stefan

Bentink

1 reference

14 December 2023

3

Thomas Risch

Thomas

Risch

1 reference

14 December 2023

4

Jian-Bing Fan

Jian-Bing

Fan

1 reference

14 December 2023

7

Renee Rubio

Renee

Rubio

1 reference

14 December 2023

15

Ursula A Matulonis

Ursula A

Matulonis

1 reference

14 December 2023

Michelle S Hirsch

5

Michelle S

Hirsch

1 reference

14 December 2023

Kristina Holton

6

Kristina

Holton

1 reference

14 December 2023

Craig April

8

Craig

April

1 reference

14 December 2023

Jing Chen

9

Jing

Chen

1 reference

14 December 2023

Joyce Liu

11

Joyce

Liu

1 reference

Creative Commons Attribution 4.0 International

14 December 2023

language of work or name

English

0 references

publication date

2012

0 references

published in

PLOS One

0 references

volume

7

0 references

issue

2

0 references

page(s)

e30269

0 references

copyright license

start time

13 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Integrated genomic analyses of ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

lumi: a pipeline for processing Illumina microarray

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Diagnosis of multiple cancer types by shrunken centroids of gene expression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

A three-gene model to robustly identify breast cancer molecular subtypes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

GeneSigDB--a curated database of gene expression signatures

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

A prognostic gene expression index in ovarian cancer - validation across different independent data sets

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Highly sensitive and specific microRNA expression profiling using BeadArray technology

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Model-based variance-stabilizing transformation for Illumina microarray data.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Discovery and validation of breast cancer subtypes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Identifying splits with clear separation: a new class discovery method for gene expression data.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030269

Predicting the clinical behavior of ovarian cancer from gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030269

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030269

Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030269

A compendium to ensure computational reproducibility in high-dimensional classification tasks.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278409

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348002

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348002

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348002

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0030269

1 reference

ADS bibcode

2012PLoSO...730269B

0 references

1 reference

1 reference

1 reference